{"entity":{"type":"insider","cik":"0001797811","url":"/insider/0001797811","json_url":"/insider/0001797811.json","name":"Perceptive LS (A), LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":5,"first":"2020-05-29","last":"2025-11-13","span_basis":"filed_date"},"name_variants":[{"name":"Perceptive LS (A), LLC","source":"filing","n_filings":5,"first_seen":"2020-05-29","last_seen":"2025-11-13"}],"transactions":[{"id":4940944,"accession":"0001193125-25-280481","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193125-25-280481","line_url":"/filing/0001193125-25-280481","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"Lyra Therapeutics, Inc.","issuer_ticker":"LYRA","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive LS (A), LLC","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31810.0,"shares_display":"31,810","price_per_share":3.9001,"price_display":"3.90","price_state":"stated","total_value":124062.181,"total_display":"124,062.18","total_whole":"124,062","shares_owned_after":124859.0,"shares_owned_after_display":"124,859","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-13","filed_date":"2025-11-13","scope":"insider","n_lines":2},{"id":4940881,"accession":"0001193125-25-280481","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-25-280481","line_url":"/filing/0001193125-25-280481","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"Lyra Therapeutics, Inc.","issuer_ticker":"LYRA","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive LS (A), LLC","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8745.0,"shares_display":"8,745","price_per_share":4.0594,"price_display":"4.06","price_state":"stated","total_value":35499.453,"total_display":"35,499.45","total_whole":"35,499","shares_owned_after":153456.0,"shares_owned_after_display":"153,456","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-12","filed_date":"2025-11-13","scope":"insider","n_lines":2},{"id":4940858,"accession":"0001193125-25-280481","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-280481","line_url":"/filing/0001193125-25-280481","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"Lyra Therapeutics, Inc.","issuer_ticker":"LYRA","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive LS (A), LLC","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5320.0,"shares_display":"5,320","price_per_share":4.3146,"price_display":"4.31","price_state":"stated","total_value":22953.672,"total_display":"22,953.67","total_whole":"22,954","shares_owned_after":161318.0,"shares_owned_after_display":"161,318","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-11","filed_date":"2025-11-13","scope":"insider","n_lines":2},{"id":4456529,"accession":"0001193125-25-274540","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193125-25-274540","line_url":"/filing/0001193125-25-274540","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"Lyra Therapeutics, Inc.","issuer_ticker":"LYRA","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive LS (A), LLC","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18502.0,"shares_display":"18,502","price_per_share":4.5398,"price_display":"4.54","price_state":"stated","total_value":83995.3796,"total_display":"83,995.38","total_whole":"83,995","shares_owned_after":166101.0,"shares_owned_after_display":"166,101","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-10","filed_date":"2025-11-10","scope":"insider","n_lines":2},{"id":4456517,"accession":"0001193125-25-274540","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-25-274540","line_url":"/filing/0001193125-25-274540","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"Lyra Therapeutics, Inc.","issuer_ticker":"LYRA","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive LS (A), LLC","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19739.0,"shares_display":"19,739","price_per_share":4.7467,"price_display":"4.75","price_state":"stated","total_value":93695.1113,"total_display":"93,695.11","total_whole":"93,695","shares_owned_after":182734.0,"shares_owned_after_display":"182,734","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-07","filed_date":"2025-11-10","scope":"insider","n_lines":2},{"id":4456510,"accession":"0001193125-25-274540","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-274540","line_url":"/filing/0001193125-25-274540","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"Lyra Therapeutics, Inc.","issuer_ticker":"LYRA","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive LS (A), LLC","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32149.0,"shares_display":"32,149","price_per_share":5.1799,"price_display":"5.18","price_state":"stated","total_value":166528.6051,"total_display":"166,528.61","total_whole":"166,529","shares_owned_after":200480.0,"shares_owned_after_display":"200,480","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-06","filed_date":"2025-11-10","scope":"insider","n_lines":2},{"id":8467228,"accession":"0001062993-23-012744","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-23-012744","line_url":"/filing/0001062993-23-012744#line-1","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"Lyra Therapeutics, Inc.","issuer_ticker":"LYRA","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; PERCEPTIVE ADVISORS LLC; EDELMAN JOSEPH; Perceptive LS (A), LLC","owner_display_name":"PERCEPTIVE LIFE SCIENCES MASTER FUND LTD","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3610832.0,"shares_display":"3,610,832","price_per_share":2.4925,"price_display":"2.49","price_state":"stated","total_value":8999998.76,"total_display":"8,999,998.76","total_whole":"8,999,999","shares_owned_after":11469117.0,"shares_owned_after_display":"11,469,117","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-31","filed_date":"2023-06-02","scope":"insider"},{"id":6453346,"accession":"0001062993-22-010256","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-010256","line_url":"/filing/0001062993-22-010256#line-1","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"Lyra Therapeutics, Inc.","issuer_ticker":"LYRA","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; Perceptive LS (A), LLC; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5924170.0,"shares_display":"5,924,170","price_per_share":4.22,"price_display":"4.22","price_state":"stated","total_value":24999997.4,"total_display":"24,999,997.40","total_whole":"24,999,997","shares_owned_after":7858285.0,"shares_owned_after_display":"7,858,285","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-12","filed_date":"2022-04-14","scope":"insider"},{"id":2100830,"accession":"0000899243-20-014580","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-014580","line_url":"/filing/0000899243-20-014580#line-1","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"Lyra Therapeutics, Inc.","issuer_ticker":"LYRA","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; Perceptive LS (A), LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":625000.0,"shares_display":"625,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","total_whole":"10,000,000","shares_owned_after":1934115.0,"shares_owned_after_display":"1,934,115","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-05","filed_date":"2020-05-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001327273","name":"Lyra Therapeutics, Inc.","url":"/issuer/0001327273","role":"Ten percent owner","n_filings":5,"first_seen":"2020-05-29","last_seen":"2025-11-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001797811","retrieved_at":"2026-08-23T07:40:59+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}